CD8A and neoplasm: We observed a two-fold increase in SL8-specific CD8+ T cells in mice that had been treated with IP2 prior to adoptive transfer of OT-1 cells (Fig. 4d) suggesting that IP2 can induce in vivo the proliferation of CD8+ T cells directed against tumor antigens.